Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:493-498

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gontijo, J. R.
Right arrow Articles by Kopp, U. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gontijo, J. R.
Right arrow Articles by Kopp, U. C.

(Hypertension. 1999;33:493-498.)
© 1999 American Heart Association, Inc.


Scientific Contributions

CGRP Activates Renal Pelvic Substance P Receptors by Retarding Substance P Metabolism

José R. Gontijo; Lori A. Smith; Ulla C. Kopp

From the Department of Internal Medicine, Department of Veterans Affairs Medical Center, and the University of Iowa College of Medicine (Iowa City).

Correspondence to Ulla C. Kopp, PhD, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA 52242. E-mail ukopp{at}blue.weeg.uiowa.edu

Abstract—Substance P and calcitonin gene–related peptide (CGRP) are colocalized in renal pelvic sensory nerves. Increasing renal pelvic pressure results in an increase in afferent renal nerve activity that is blocked by a substance P receptor antagonist but not by a CGRP receptor antagonist. CGRP potentiates the effects of substance P by preventing the metabolism of substance P. Therefore, we examined whether CGRP enhanced the afferent renal nerve activity responses to substance P and increased renal pelvic pressure, a stimulus known to increase substance P release. Combined administration of substance P and CGRP into the renal pelvis resulted in an increase in afferent renal nerve activity (1392±217% · s; area under the curve of afferent renal nerve activity versus time) that was greater (P<0.01) than that produced by substance P (620±156% · s) or CGRP (297±96% · s) alone. Likewise, CGRP enhanced the afferent renal nerve activity response to increased renal pelvic pressure. During renal pelvic administration of the neutral endopeptidase inhibitor thiorphan, the afferent renal nerve activity response to substance P plus CGRP was similar to that produced by either neuropeptide alone. Because these studies suggested that CGRP potentiated the afferent renal nerve activity responses to substance P, we examined whether the afferent renal nerve activity response to CGRP was blocked by a substance P receptor antagonist, RP67580. RP67580 blocked the afferent renal nerve activity response to CGRP by 85±12% (P<0.02). We conclude that CGRP activates renal pelvic sensory nerves by retarding the metabolism of substance P, thereby increasing the amount of substance P available for stimulation of substance P receptors.


Key Words: sensory neurons • endopeptidase, neutral • afferent renal nerve




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
N. A. Lutaif, E. M. Rocha, L. A. Veloso, L. M. Bento, and J. A. R. Gontijo
Renal contribution to thermolability in rats: role of renal nerves
Nephrol. Dial. Transplant., July 1, 2008; (2008) gfn368v1.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Xie, J. R. Sachs, and D. H. Wang
Interdependent Regulation of Afferent Renal Nerve Activity and Renal Function: Role of Transient Receptor Potential Vanilloid Type 1, Neurokinin 1, and Calcitonin Gene-Related Peptide Receptors
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 751 - 757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N.-H. Feng, H.-H. Lee, J.-C. Shiang, and M.-C. Ma
Transient receptor potential vanilloid type 1 channels act as mechanoreceptors and cause substance P release and sensory activation in rat kidneys
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F316 - F325.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Bolli and A. Abdel-Latif
No Pain, No Gain: The Useful Function of Angina
Circulation, December 6, 2005; 112(23): 3541 - 3543.
[Full Text] [PDF]


Home page
CirculationHome page
L. Wang and D. H. Wang
TRPV1 Gene Knockout Impairs Postischemic Recovery in Isolated Perfused Heart in Mice
Circulation, December 6, 2005; 112(23): 3617 - 3623.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Zhu, Y. Wang, and D. H. Wang
Diuresis and Natriuresis Caused by Activation of VR1-Positive Sensory Nerves in Renal Pelvis of Rats
Hypertension, October 1, 2005; 46(4): 992 - 997.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
U. C. Kopp, M. Z. Cicha, K. Nakamura, R. M. Nusing, L. A. Smith, and T. Hokfelt
Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves
Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1269 - F1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp, M. Z. Cicha, and L. A. Smith
PGE2 increases release of substance P from renal sensory nerves by activating the cAMP-PKA transduction cascade
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1618 - R1627.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp, M. Z. Cicha, L. A. Smith, and T. Hokfelt
Nitric oxide modulates renal sensory nerve fibers by mechanisms related to substance P receptor activation
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R279 - R290.
[Abstract] [Full Text] [PDF]